Author Profile
Matherne, G. (Paul)
Reversing Sickle Cell Disease: A Crisp Deal?
Matherne, G. (Paul); Herpfer, Christoph; Dow, Ethan
OM-1795 | Published November 12, 2025 | 11 pages. Case
Collection: Darden School of Business
Carmen Jones, principal at a venture capital firm in the biotechnology industry, pondered the latest deal the firm was considering. It had recently closed a $700 million fund and was evaluating severa... Read More
Health Insurance Challenges
S-0464 | Published January 07, 2025 | 2 pages. Case
Collection: Darden School of Business
This set of caselets includes three health insurance scenarios designed for an in-class exercise within a session focusing on the health insurance industry and health care. These scenarios provide per... Read More
Venture Capital in Biotechnology
Matherne, G. (Paul); Herpfer, Christoph; Dow, Ethan
OM-1796 | Published December 05, 2023 | 8 pages. Technical Note
Collection: Darden School of Business
Pharmaceutical companies have historically relied on their ability to research, develop, manufacture, and sell drug products. Developing a successful drug is a complex and lengthy process, with no gua... Read More
When Competition Isn't Enough: Rural Health in Southwest Virginia (A)
Matherne, G. (Paul); Goldberg, Rebecca; Bermel, Peggy; Fox, Brennan; Minogue, Kevin; Oberleitner, Ryan; Punches, Charlie; Rose, Caroline
S-0314 | Published September 06, 2019 | 14 pages. Case
Collection: Darden School of Business
Mark Seidman at the Federal Trade Commission is evaluating a proposed merger between two health care entities and competing market leaders in southwest Virginia. The rural region is characterized by p... Read More